Irma Bagdoniene: From Estimating Risk to Seeing Disease in Preventive Cardiology
Irma Bagdoniene, Cardiologist Specializing in Prevention and Lipidology, shared a post on LinkedIn about a recent article by Kenrick Schulze et al, published in Nature Reviews Cardiology:
”Are we still estimating risk when we can actually see it?
In preventive cardiology, risk used to be something we calculated.
Today, with coronary CT angiography, it is something we can see.
CCTA reveals both calcified and soft plaque — the atherosclerosis that traditional risk scores cannot capture. Registry data from confirm, advance, and decide show that plaque burden and high-risk plaque features predict events better than calcium score or stenosis alone, especially in patients who live in the preventive ‘gray zone’.
Instead of reacting to events, we can identify disease early and personalize preventive therapy based on the plaque we observe within the vessel wall.
To prevent myocardial infarction, we must move from estimating risk to treating the disease we can now visualize.
Title: Coronary CT angiography evaluation with artificial intelligence for individualized medical treatment of atherosclerosis: a Consensus Statement from the QCI Study Group
Authors: Kenrick Schulze, Anne-Marieke Stantien, Michelle C. Williams, Vassilios S. Vassiliou, Andreas A. Giannopoulos, Koen Nieman, Pál Maurovich-Horvat, Jason M. Tarkin, Rozemarijn Vliegenthart, Jonathan Weir-McCall, Mahmoud Mohamed, Bernhard Föllmer, Federico Biavati, Ann-Christine Stahl, Jakob Knape, Hanna Balogh, Nicola Galea, Ivana Išgum, Armin Arbab-Zadeh, Hatem Alkadhi, Robert Manka, David A. Wood, Edward D. Nicol, Nick S. Nurmohamed, Fabrice M. A. C. Martens, Damini Dey, David E. Newby, Marc Dewey
Read the Full Article on Nature Reviews Cardiology․
Stay updated on all scientific advances with Hemostasis Today.
-
Mar 6, 2026, 16:51Priya Reehal: Highlighting The Central Role of Nurses in Cardio-Oncology
-
Mar 6, 2026, 16:50Rainer Kaiser: Blinatumomab Shows Remarkable Response in Multi-Refractory ITP and APS
-
Mar 6, 2026, 16:18Laila Shalabi: Clopidogrel, Aspirin, and the Role of PPIs in Coronary Artery Disease
-
Mar 6, 2026, 16:17Paul McKenzie: The Value of Gene Therapy in Bleeding Disorders
-
Mar 6, 2026, 16:15Basma El Homasany: The ‘Little Brain’ of the Heart and Its Role in Health
-
Mar 6, 2026, 16:14Jamal Rana: Family History and Polygenic Risk for Coronary Heart Disease
-
Mar 6, 2026, 15:43Kristy Ainslie: Breaking Down the Discovery and FDA Approval of Drug Carriers
-
Mar 6, 2026, 15:18Claudio Laudani: Efficacy and Safety of Colchicine for Secondary Prevention in Coronary Artery Disease
-
Mar 6, 2026, 15:09Chris Simon: Persona PLUS Receives FDA Clearance for Patent‑Protected Plasma Apheresis